NextPlat Q3 revenue $13.8M, net loss narrows 48% YoY; sees Q4 improvement

NextPlat Corp

Revenue $13.8M down from $15.4M YoY; gross margin 19.9% vs 23.2%.
Net loss to common $2.2M ($0.08/sh) vs $4.2M ($0.22); cash $13.9M.
OpEx cut to $4.7M from $7.8M; annual overhead reduced >$2M via headcount cuts.
Healthcare added 3,000+ high-margin prescriptions/month; expanded government subcontract.
e-Commerce: GTC exclusive Nordic distributor; OPKO China sell-through high; FL Sunshine in UK/EU.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.